Evidence map›Paper›PMID 39605440›Full record

ArticlebioRxiv : the preprint server for biology2025

A whole-animal phenotypic drug screen identifies suppressors of atherogenic lipoproteins.

Daniel J Kelpsch, Liyun Zhang, James H Thierer, Kobe Koren, Urmi Kumar, Yuki Lin, Monica R Hensley, Mira Sohn, Jun O Liu, Thomas Lectka and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Daniel J KelpschDepartment of Biology, Johns Hopkins University, Baltimore, United States.ORCID 0000-0002-7383-5530
Liyun ZhangDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, United States.
James H ThiererDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, United States.
Kobe KorenDepartment of Biology, Johns Hopkins University, Baltimore, United States.ORCID 0009-0008-2813-2255
Urmi KumarDepartment of Biology, Johns Hopkins University, Baltimore, United States.
Yuki LinDepartment of Biology, Johns Hopkins University, Baltimore, United States.
Monica R HensleyDepartment of Biology, Johns Hopkins University, Baltimore, United States.
Mira SohnDepartment of Biology, Johns Hopkins University, Baltimore, United States.
Jun O LiuDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, United States.
Thomas LectkaDepartment of Chemistry, Johns Hopkins University, Baltimore, United States.
Jeff S MummDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, United States.ORCID 0000-0002-2575-287X
Steven A FarberDepartment of Biology, Johns Hopkins University, Baltimore, United States.ORCID 0000-0002-8037-7312

Funding

Wilmer Core Grant for Vision ResearchP30EY001765 · NEI · JOHNS HOPKINS UNIVERSITY · PI JEFFREY MUMM · 1985 to 2026
$22.1M
Cellular and Molecular BiologyT32GM141804 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI John Kim · 2021 to 2026
$5.1M
In vivo HTS assay for novel modulators of Apolipoprotien BR01DK116079 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI FARBER, STEVEN A · 2018 to 2022
$3.2M
High-throughput Phenotypic Screening (HPS) Platform for Large-scale Drug Discovery in Whole-organism and Human Organoid-based Disease ModelsS10OD026909 · OD · JOHNS HOPKINS UNIVERSITY · PI MUMM, JEFFREY · 2020 to 2020
$1.9M
Defining the role of PLA2G12B on apoB-containing lipoprotein assembly, plasma levels, metabolism and cardiovascular disease riskR01DK138195 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI STEVEN A FARBER, M Mahmood Hussain · 2025 to 2026
$1.2M
A whole-animal small molecule screen to identify and characterize modifiers of Apolipoprotein BF32DK126297 · NIDDK · CARNEGIE INSTITUTION OF WASHINGTON, D.C. · PI KELPSCH, DANIEL · 2020 to 2022
$201k
NEI NIH HHS P30 EY001765NIDDK NIH HHS F32 DK126297NIDDK NIH HHS R01 DK116079NIDDK NIH HHS R01 DK138195NIGMS NIH HHS T32 GM141804NIH HHS S10 OD026909
6 · The paper itself

Abstract

Lipoproteins are essential for lipid transport in all bilaterians. A single Apolipoprotein B (ApoB) molecule is the inseparable structural scaffold of each ApoB-containing lipoprotein (B-lps), which are responsible for transporting lipids to peripheral tissues. The cellular mechanisms that regulate ApoB and B-lp production, secretion, transport, and degradation remain to be fully defined. In humans, elevated levels of vascular B-lps play a causative role in cardiovascular disease. Previously, we have detailed that human B-lp biology is remarkably conserved in the zebrafish using an

Identifiers

PMID39605440
PMCPMC11601432

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.